Jaguar Health (JAGX) Times Interest Earned (2014 - 2026)
Jaguar Health (JAGX) reported Times Interest Earned of $14.57 for Q1 2026, down 91.34% year-over-year from $168.23 in Q1 2025, and up 109.05% quarter-over-quarter from -$160.92 in Q4 2025.
Jaguar Health (JAGX) Times Interest Earned (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Times Interest Earned data on file, last reported at $14.57 in Q1 2026.
- Times Interest Earned for Q1 2026 came in at $14.57, down 91.34% year-over-year; the trailing twelve-month figure through Mar 2026 was -$32.0 (down 143.55% YoY), and the FY2025 annual result was -$685.19, down 413.38% from the prior year.
- Times Interest Earned grew to $14.57 in Q1 2026 per JAGX's latest filing, from -$160.92 in the prior quarter.
- Over five years, Times Interest Earned peaked at $533.8 in Q2 2025 and troughed at -$1206.3 in Q3 2025.
- A 5-year average of -$33.77 and a median of -$2.47 in 2022 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned surged 2940.09% in 2024, then sank 2791.08% in 2025.
- A 5-year view of Times Interest Earned shows it stood at -$2.39 in 2022, then slumped by 1176.85% to -$30.47 in 2023, then soared by 343.35% to $74.15 in 2024, then sank by 317.01% to -$160.92 in 2025, then jumped by 109.05% to $14.57 in 2026.
- Business Quant data shows JAGX's Times Interest Earned at $14.57 in Q1 2026, -$160.92 in Q4 2025, and -$1206.3 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -258.33 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 11.79 |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 14.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.57 |
| Dec 31, 2025 | -160.92 |
| Sep 30, 2025 | -1,206.33 |
| Jun 30, 2025 | 533.80 |
| Mar 31, 2025 | 168.23 |
| Dec 31, 2024 | 74.15 |
| Sep 30, 2024 | 44.83 |
| Jun 30, 2024 | 66.64 |
| Mar 31, 2024 | -13.45 |
| Dec 31, 2023 | -30.47 |
| Sep 30, 2023 | -17.57 |
| Jun 30, 2023 | -2.35 |
| Dec 31, 2022 | -2.39 |
| Sep 30, 2022 | -3.62 |
| Jun 30, 2022 | -2.55 |
| Mar 31, 2022 | -2.80 |
| Dec 31, 2021 | -4.45 |
| Sep 30, 2021 | -4.59 |
| Jun 30, 2021 | -5.76 |
| Mar 31, 2021 | -4,383.00 |